[ NEWS ]

Improved Hardness and Wear Resistance with IonGuard®

Many medical device companies turn to N2 Biomedical to improve the wear resistance and hardness of Titanium and Cobalt Chromium implants using its IonGuard® Ion Implantation process. The increased diagnosis of patients with nickel allergies has increased the demand for titanium implants. However, untreated titanium articulating surfaces have been shown to produce metallic particles resulting in an adverse tissue response […]

Read More
Metal orthopedic balls and joints

N2 Biomedical awarded two patents for proprietary infection prevention, bone integration processes

Patents awarded for Dual Action NanoCoating, Mesoporous Surface for Enhanced Bone Integration BEDFORD, Mass. – June 29, 2020 – N2 Biomedical, a leading provider of coatings and surface treatment solutions to the medical device industry, was recently awarded two patents by the United States Patents Office: one for their proprietary Dual Action NanoCoating, and one for their Mesoporous Surface for […]

Read More
Metal orthopedic balls and joints

Performance Advantages of IonGuard® Ion Implantation Treatment for Titanium-based Orthopedic Implants

Titanium is generally recognized as one of the most biocompatible materials with many properties that make it ideal for bone and joint replacement applications, such as a low modulus of elasticity, excellent fatigue and tensile strength, and low weight/density. Untreated titanium, however, has lower wear resistance compared to other metallic alloys such as CoCr 1,2 and should not be used […]

Read More

MDM Minneapolis

Minneapolis, October 28-29, 2020 Minneapolis Convention Center

Read More
Metal orthopedic balls and joints

N2 Biomedical announces expansion of team, acquisition by Ampersand

Bedford-based company embraces recapitalization, internal team’s growth BEDFORD, Mass. – February 10, 2020 – N2 Biomedical, a leading provider of coating and surface treatment solutions to the medical device industry, announced several personnel changes to support its growth following a recent majority recapitalization of the company by Ampersand Capital Partners. As part of the transaction, N2 Biomedical announced the appointments […]

Read More
Metal orthopedic balls and joints

Ampersand completes growth equity investment in N2 Biomedical

Bedford, MA – June 18, 2019: N2 Biomedical, a leading provider of coating and surface treatment solutions to the medical device industry, announced today the majority recapitalization of the company by Ampersand Capital Partners. As part of the transaction N2 also announced the appointment of Randall Sword, an executive with 30 years of experience in the medical device sector, as […]

Read More